- Emerging biosimilars like Omalizumab, Natalizumab, and Tocilizumab are gaining first approvals in both regions
Berkowitz, S
CrossRef High salt supplementation of a MASH-inducing diet causes lean MASH phenotype with increased hepatic urea cycle activity and EIF5A hypusination Shaopeiwen Luo, Norihiko Morisawa, Anissa Anindya Widjaja, Brijesh Kumar Singh, Derek John Hausenloy, Paul Michael Yen, Jin Zhou Molecular Metabolism .2026
27.5 points) and greater SF-36 physical function improvement (12 points vs
Poor sleep can worsen glucose tolerance and insulin sensitivity, creating a constant loop of fatigue
By targeting the oligodendrocytes' mitochondria, the copper chelator neurotoxicant cuprizone disrupts the brain's energy metabolism (15)